Evidence map›Paper›PMID 35613837›Full record

ReviewBMJ global health2022

A 'whole of United Nations approach' to tackle antimicrobial resistance? A mapping of the mandate and activities of international organisations.

Didier Wernli, Stephan Harbarth, Nicolas Levrat, Didier Pittet

Open access · goldAbstract readReview
In one paragraph

Review in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Socioeconomic Disparities and the Prevalence of Antimicrobial Resistance.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Antimicrobial resistance and One Health.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2022
    Review
  19. Digoxin Derivatives Sensitize aJournal of fungi (Basel, Switzerland) · 2022
    Article
  20. A Pandemic Instrument can Optimize the Regime Complex for AMR by Striking a Balance between Centralization and Decentralization.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Didier WernliGeneva Transformative Governance Lab, Global Studies Institute, University of Geneva, Geneva, Switzerland didier.wernli@unige.ch.ORCID 0000-0002-1751-1961
Stephan HarbarthInfection Control Programme, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
Nicolas LevratGeneva Transformative Governance Lab, Global Studies Institute, University of Geneva, Geneva, Switzerland.
Didier PittetInfection Control Programme, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
University of Geneva · CH

Funding

Wellcome Trust
6 · The paper itself

Abstract

The 2015 World Health Organization Global Action Plan and other international policy documents have stressed the need for a 'whole of United Nations approach' in addressing antimicrobial resistance (AMR). As several years have passed, the goal of this paper is to take stock of the current role, mandate, and activities of international organisations and other global stakeholders on AMR. Relevant information is identified through a web-based search and a review of policy documents from international organisations. Based on the assessment of 78 organisations, 21 have AMR-specific activities in the broader sense, although for many of these organisations, their involvement is limited in scope, and 36 have AMR-sensitive activities reflecting the wide scope of AMR. An interdisciplinary framework based on six relevant challenges of global collective actions regarding AMR as well as the main functions of international organisations in global governance is used to organise the findings into several 'clusters'. AMR is not a priority for many international organisations, but some of them can leverage current efforts to tackle AMR while contributing to their core agenda. Overall, a 'whole of UN approach' to AMR within the framework of Sustainable Development Goals is critical to move the global governance of AMR forward.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialHumansUnited NationsWorld Health OrganizationAnti-Bacterial Agentshealth policies and all other topicsinfections, diseases, disorders, injuries

Identifiers

PMID35613837
PMCPMC9134163
OpenAlexW4281568742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.